alovudine has been researched along with Glioma in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 15 (39.47) | 29.6817 |
2010's | 23 (60.53) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eimer, S; Fernandez, P; Gimbert, E; Lamare, F; Ledure, S; Loiseau, H; Monteil, P; Penchet, G; Perez, P; Tourdias, T; Vimont, D; Zanotti-Fregonara, P | 1 |
Angelidis, G; Efthimiadou, R; Fountas, K; Georgoulias, P; Nikaki, A; Prasopoulos, V; Tsougos, I; Valotassiou, V | 1 |
Haba, R; Kawai, N; Kudomi, N; Kushida, Y; Miyake, K; Nakamura, T; Okada, M; Shinomiya, A; Tamiya, T; Tokuda, M | 1 |
Cloughesy, TF; Dahlbom, M; Huang, SC; Phelps, ME; Schiepers, C; Wardak, M | 1 |
Belohlavek, O; Benes, V; Fencl, P; Jaruskova, M; Majovsky, M | 1 |
Chen, Z; Cui, Y; Fu, Z; Kong, L; Li, M; Yang, G; Yu, J; Zhao, F | 1 |
Chen, Z; Cui, Y; Fu, Z; Li, M; Wang, Z; Yu, J; Zhao, F | 1 |
Abbas, A; Barré, L; Bernaudin, M; Collet, S; Constans, JM; Delcroix, N; Derlon, JM; Guillamo, JS; Ibazizene, M; Lechapt-Zalcman, E; Roussel, S; Valable, S | 1 |
Anish, B; Hazari, PP; Kumar, N; Mishra, AK; Rani, N; Sharma, S; Singh, B; Vyas, S; Watts, A | 1 |
Kudomi, N; Maeda, Y; Mitamura, K; Miyake, K; Nishiyama, Y; Norikane, T; Yamamoto, Y | 1 |
Bag, AK; Desai, AS; Desideri, S; Fisher, JD; Grossman, SA; Holdhoff, M; Leal, JP; Lesser, GJ; Lieberman, FS; Lodge, MA; Mankoff, DA; Mintz, A; Mountz, JM; Nabors, LB; Schiff, D; Wahl, RL; Ye, X | 1 |
Hatakeyama, T; Ichikawa, T; Kawai, N; Nishiyama, Y; Sasakawa, Y; Tamiya, T; Yamamoto, Y | 1 |
Eary, JF; Hoffman, JM; Krohn, KA; Link, JM; Muzi, M; Spence, AM | 1 |
Aigbirhio, FI; Burnet, NG; Clark, JC; Cleij, MC; Dean, AF; Fryer, TD; Gillard, JH; Hutchinson, PJ; Joseph, J; Pickard, JD; Price, SJ; Salvador, R; Wang, DD | 1 |
Backes, H; Jacobs, AH; Kracht, L; Neumaier, B; Ullrich, R; Wienhard, K | 1 |
D'Souza, M; Datta, A; Garg, G; Grover, RK; Jaimini, A; Kumar, N; Mishra, AK; Mondal, A; Panwar, P; Sharma, R; Singh, D; Tripathi, M; Varshney, R | 1 |
Chen, W; Cloughesy, T; Czernin, J; Dahlbom, M; Huang, SC; Phelps, ME; Schiepers, C | 1 |
Ameli, M; Fraefel, C; Galldiks, N; Heiss, WD; Hesselmann, V; Jacobs, AH; Li, H; Rueckriem, B; Rueger, MA; Vollmar, S; Wienhard, K; Winkeler, A | 1 |
Burkholder, I; Combs, SE; Essig, M; Giesel, FL; Haberkorn, U; Henze, M; Kauczor, HU; Kroll, A; Meissner, M; Stieltjes, B; Tüttenberg, J; Vogt-Schaden, M; Weber, MA; Zimmer, F; Zoubaa, S | 1 |
Delattre, JY; Goldman, S; Petrirena, GJ | 1 |
Chen, W; Cloughesy, T; Czernin, J; Dahlbom, M; Huang, SC; Phelps, ME; Satyamurthy, N; Schiepers, C; Wardak, M | 1 |
Chen, W; Cloughesy, TF; Czernin, J; Dahlbom, M; Ellingson, BM; Geist, C; Phelps, ME; Pope, WB; Satyamurthy, N; Schwarzenberg, J; Silverman, DH | 1 |
Jeong, SY; Lim, SM | 1 |
Hatakeyama, T; Kawai, N; Miyake, K; Okada, M; Shinomiya, A; Tamiya, T | 1 |
Boucher, KM; Butterfield, RI; Christian, PE; Enslow, MS; Heilbrun, ME; Hoffman, JM; Jensen, RL; Kadrmas, DJ; Morton, KA; Zollinger, LV | 1 |
Boogaarts, HD; Grotenhuis, JA; Heerschap, A; Hoffmann, AL; Idema, AJ; Oyen, WJ; Troost, EG; van der Graaf, WT; Wesseling, P | 1 |
Aga, F; Kawai, N; Kudomi, N; Nishiyama, Y; Ono, Y; Yamamoto, Y | 1 |
Haba, R; Kawai, N; Kudomi, N; Kushida, Y; Miyake, K; Nakamura, T; Okada, M; Shinomiya, A; Tamiya, T; Tokuda, M; Yamamoto, Y | 1 |
Cobben, DC; de Vries, EF; Elsinga, PH; Hoekstra, HJ; Jager, PL; Maas, B; Suurmeijer, AJ; Vaalburg, W; van Waarde, A | 1 |
Bergsneider, M; Chen, W; Cloughesy, T; Czernin, J; Kamdar, N; Liau, L; Mischel, P; Phelps, ME; Satyamurthy, N; Silverman, DH | 1 |
Cheng, Z; Dandekar, M; Gambhir, SS; Louie, S; Park, JM; Subbarayan, M; Tseng, JR | 1 |
Dittmar, C; Galldiks, N; Garlip, G; Heiss, WD; Herholz, K; Hilker, R; Jacobs, AH; Klein, JC; Kracht, LW; Li, H; Sobesky, J; Thomas, A; Vollmar, S; Wienhard, K | 1 |
Fujibayashi, Y; Furukawa, T; Kado, H; Kawai, H; Kubota, T; Nakagawa, T; Takamatsu, S; Toyohara, J; Yonekura, Y | 1 |
Gault, N; Grahek, D; Gutman, F; Kerrou, K; Montravers, F; Schlienger, M; Talbot, JN; Touboul, E | 1 |
Grierson, JR; Krohn, KA; Link, JM; Mankoff, DA; Muzi, M; O'Sullivan, F; Spence, AM; Wells, JM | 1 |
Dittmar, C; Fraefel, C; Graf, R; Heiss, WD; Heneka, MT; Herrlinger, U; Jacobs, AH; Klein, M; Kummer, C; Li, H; Rueckriem, B; Rueger, MA; Vollmar, S; Waerzeggers, Y; Wienhard, K; Winkeler, A | 1 |
Bradbury, MS; Burnazi, EM; Cai, S; Hambardzumyan, D; Holland, EC; Larson, SM; Longo, V; Schwartz, J; Zanzonico, PB | 1 |
Backes, H; Heiss, WD; Jacobs, AH; Kesper, K; Kracht, L; Li, H; Miletic, H; Neumaier, B; Ullrich, R; Wienhard, K | 1 |
3 review(s) available for alovudine and Glioma
Article | Year |
---|---|
Topics: Biomarkers, Tumor; Dideoxynucleosides; Glioma; Humans; Neoplasm Grading; Positron-Emission Tomography; Treatment Outcome | 2017 |
Advances in PET imaging of brain tumors: a referring physician's perspective.
Topics: Brain Neoplasms; Carbon Radioisotopes; Dideoxynucleosides; Fluorine Radioisotopes; Glioblastoma; Glioma; Humans; Methionine; Nitroimidazoles; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2011 |
[PET and malignant cerebral tumors].
Topics: Brain Neoplasms; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
6 trial(s) available for alovudine and Glioma
Article | Year |
---|---|
Prognostic value of 3'-deoxy-3'-18F-fluorothymidine ([(18)F] FLT PET) in patients with recurrent malignant gliomas.
Topics: Adult; Aged; Brain Neoplasms; Dideoxynucleosides; Female; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Recurrence; Survival Analysis | 2014 |
NCI-sponsored trial for the evaluation of safety and preliminary efficacy of FLT as a marker of proliferation in patients with recurrent gliomas: safety studies.
Topics: Adult; Biomarkers; Carbon Dioxide; Cell Proliferation; Creatine; Dideoxynucleosides; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Glioma; Humans; Male; Middle Aged; National Cancer Institute (U.S.); Neoplasm Recurrence, Local; Positron-Emission Tomography; Potassium; United States | 2008 |
3'-deoxy-3'-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab.
Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Biological Transport; Dideoxynucleosides; Disease-Free Survival; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Time Factors; Treatment Outcome | 2012 |
Comparison of 3'-deoxy-3'-[18F]fluorothymidine PET and O-(2-[18F]fluoroethyl)-L-tyrosine PET in patients with newly diagnosed glioma.
Topics: Adult; Aged; Brain Neoplasms; Dideoxynucleosides; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Prospective Studies; Tyrosine | 2012 |
Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma.
Topics: Adult; Aged; Diagnosis, Differential; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Necrosis; Neoplasm Grading; Positron-Emission Tomography; Radiation Injuries; Recurrence; Young Adult | 2012 |
3'-Deoxy-3'-18F-fluorothymidine PET-derived proliferative volume predicts overall survival in high-grade glioma patients.
Topics: Adult; Aged; Biological Transport; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Tumor Burden | 2012 |
29 other study(ies) available for alovudine and Glioma
Article | Year |
---|---|
Combining 3'-Deoxy-3'-[18F] fluorothymidine and MRI increases the sensitivity of glioma volume detection.
Topics: Adult; Aged; Biological Transport; Cell Proliferation; Dideoxynucleosides; Female; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; Tumor Burden | 2019 |
3'-Deoxy-3'-[(18)F]-fluorothymidine ([(18)F]-FLT) transport in newly diagnosed glioma: correlation with nucleoside transporter expression, vascularization, and blood-brain barrier permeability.
Topics: Adult; Aged; Antigens, CD34; Biological Transport; Blood-Brain Barrier; Brain Neoplasms; Dideoxynucleosides; Equilibrative Nucleoside Transporter 1; Female; Fluorine Radioisotopes; Glioma; Humans; Male; Middle Aged; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; RNA, Messenger; Young Adult | 2013 |
¹⁸F-FLT and ¹⁸F-FDOPA PET kinetics in recurrent brain tumors.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasms; Camptothecin; Data Interpretation, Statistical; Dideoxynucleosides; Dihydroxyphenylalanine; Female; Glioma; Humans; Irinotecan; Kinetics; Male; Middle Aged; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tissue Distribution | 2014 |
FLT-PET in previously untreated patients with low-grade glioma can predict their overall survival.
Topics: Adult; Aged; Dideoxynucleosides; Disease-Free Survival; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography | 2014 |
(18)F-Fluorothymidine PET-CT for resected malignant gliomas before radiotherapy: tumor extent according to proliferative activity compared with MRI.
Topics: Adult; Aged; Brain Neoplasms; Dideoxynucleosides; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm, Residual; Positron-Emission Tomography; Postoperative Period; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden | 2015 |
[(18)F]-fluoro-L-thymidine PET and advanced MRI for preoperative grading of gliomas.
Topics: Adult; Aged; Brain Neoplasms; Dideoxynucleosides; Female; Fluorine Radioisotopes; Glioma; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Preoperative Period | 2015 |
99mTc-MDM Brain SPECT for the Detection of Recurrent/Remnant Glioma-Comparison With ceMRI and 18F-FLT PET Imaging: Initial Results.
Topics: Adult; Aged; Brain Neoplasms; Dideoxynucleosides; Female; Glioma; Humans; Male; Middle Aged; Organotechnetium Compounds; Pentetic Acid; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2015 |
Intratumoral heterogeneity of
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Brain Neoplasms; Cell Proliferation; Child; Dideoxynucleosides; Female; Glioma; Humans; Ki-67 Antigen; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Young Adult | 2017 |
Repeatability of
Topics: Adult; Brain Neoplasms; Dideoxynucleosides; Female; Glioma; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Grading; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; United States | 2017 |
11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Cell Proliferation; Child; Child, Preschool; Dideoxynucleosides; Female; Glioma; Humans; Immunohistochemistry; Male; Methionine; Middle Aged; Positron-Emission Tomography | 2008 |
Imaging regional variation of cellular proliferation in gliomas using 3'-deoxy-3'-[18F]fluorothymidine positron-emission tomography: an image-guided biopsy study.
Topics: Adolescent; Adult; Aged; Biopsy; Brain Mapping; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiology, Interventional; Radiopharmaceuticals; Sensitivity and Specificity; Young Adult | 2009 |
Noninvasive quantification of 18F-FLT human brain PET for the assessment of tumour proliferation in patients with high-grade glioma.
Topics: Arteries; Brain; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Glioma; Humans; Kinetics; Models, Biological; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies | 2009 |
Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Dideoxynucleosides; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2009 |
Kinetics of 3'-deoxy-3'-18F-fluorothymidine during treatment monitoring of recurrent high-grade glioma.
Topics: Adult; Aged; Brain Neoplasms; Dideoxynucleosides; Female; Glioma; Humans; Image Processing, Computer-Assisted; Kinetics; Male; Middle Aged; Models, Statistical; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis; Survivors; Treatment Outcome | 2010 |
[18F]FLT PET for non-invasive monitoring of early response to gene therapy in experimental gliomas.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Gene Expression; Genetic Therapy; Glioma; Green Fluorescent Proteins; Humans; Mice; Mice, Nude; Positron-Emission Tomography; Time Factors; Treatment Outcome; Xenograft Model Antitumor Assays | 2011 |
Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Biopsy; Brain Neoplasms; Choline; Contrast Media; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Microcirculation; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Spin Labels; Stereotaxic Techniques | 2010 |
Discriminant analysis of ¹⁸F-fluorothymidine kinetic parameters to predict survival in patients with recurrent high-grade glioma.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Camptothecin; Dideoxynucleosides; Discriminant Analysis; Disease-Free Survival; Female; Glioma; Humans; Irinotecan; Male; Middle Aged; Prognosis; Radionuclide Imaging | 2011 |
Usefulness of FDG, MET and FLT-PET studies for the management of human gliomas.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Glioma; Humans; Linear Models; Male; Methionine; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Statistics, Nonparametric | 2012 |
Correlation of 18F-FLT uptake with tumor grade and Ki-67 immunohistochemistry in patients with newly diagnosed and recurrent gliomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Brain Neoplasms; Child; Dideoxynucleosides; Female; Glioma; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Neoplasm Grading; Recurrence; Retrospective Studies; Young Adult | 2012 |
Evaluation of 3'-deoxy-3'-[18F]-fluorothymidine (18F-FLT) kinetics correlated with thymidine kinase-1 expression and cell proliferation in newly diagnosed gliomas.
Topics: Adult; Aged; Blood-Brain Barrier; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glioma; Humans; Immunohistochemistry; Kinetics; Magnetic Resonance Imaging; Male; Middle Aged; Phosphorylation; Polymerase Chain Reaction; Thymidine Kinase | 2013 |
Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.
Topics: Animals; Diagnosis, Differential; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Glioma; Inflammation; Male; Metabolic Clearance Rate; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Reproducibility of Results; Rodentia; Sensitivity and Specificity; Tissue Distribution; Turpentine | 2004 |
Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
Topics: Adult; Aged; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Ki-67 Antigen; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate | 2005 |
Reproducibility of 3'-deoxy-3'-(18)F-fluorothymidine microPET studies in tumor xenografts in mice.
Topics: Animals; Cell Line, Tumor; Dideoxynucleosides; Female; Glioma; Image Enhancement; Image Interpretation, Computer-Assisted; Mice; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Reproducibility of Results; Sensitivity and Specificity | 2005 |
18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
Topics: Adult; Aged; Antiviral Agents; Astrocytoma; Biological Transport; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; False Positive Reactions; Female; Glioma; Humans; Kinetics; Magnetic Resonance Imaging; Male; Medulloblastoma; Methionine; Middle Aged; Phosphorylation; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors | 2005 |
Acquisition of resistance to antitumor alkylating agent ACNU: a possible target of positron emission tomography monitoring.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cell Survival; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Glioma; Nimustine; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rats; Treatment Outcome | 2006 |
Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas.
Topics: Adult; Aged; Blood-Brain Barrier; Brain Neoplasms; Dideoxynucleosides; Female; Gadolinium; Glioma; Humans; Male; Middle Aged; Models, Biological; Monte Carlo Method; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals | 2006 |
Imaging-guided gene therapy of experimental gliomas.
Topics: Animals; Cell Line, Tumor; Dideoxynucleosides; Fluorine Radioisotopes; Genetic Therapy; Glioma; Humans; Image Processing, Computer-Assisted; Mice; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude | 2007 |
Dynamic small-animal PET imaging of tumor proliferation with 3'-deoxy-3'-18F-fluorothymidine in a genetically engineered mouse model of high-grade gliomas.
Topics: Animals; Brain Neoplasms; Dideoxynucleosides; Disease Models, Animal; Glioma; Iodine Radioisotopes; Metabolic Clearance Rate; Mice; Mice, Knockout; Mice, Transgenic; Positron-Emission Tomography; Tissue Distribution | 2008 |
Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma.
Topics: Adult; Aged; Brain Neoplasms; Carbon Radioisotopes; Cell Proliferation; Dideoxynucleosides; Female; Fluorine Radioisotopes; Glioma; Humans; Immunohistochemistry; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2008 |